Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
Status:
Not yet recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about how adult and children's bodies use
etanercept and how bodyweight influences how well etanercept works. This study will help us
understand the proper dose of etanercept in obese children and adults.
Phase:
Phase 1
Details
Lead Sponsor:
Duke University
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)